Prof. El Aidy wins Gut Microbiome Therapeutic Innovation challenge
Prof. Sahar El Aidy from the Groningen Biomolecular Sciences and Biotechnology Institute ( GBB ) has won the ProDigest and CosmosID Gut Microbiome Therapeutic Innovation ( GMTI ) challenge out of almost fifty submissions from all over the world. Prof. El Aidy won the challenge with her research plan to investigate the ‘Role of anti-Parkinson’s Disease (PD) medication in enhancing bacterial overgrowth and community dynamics along the gastrointestinal tract’. She receives EUR 50,000 to conduct her project on ProDigest’s gastrointestinal SHIME® platform, an in vitro simulator of the gastrointestinal tract.
The aim of the project is to identify which gut bacterial metabolites can improve or impair communication with the host gut-brain axis and effectiveness of drug treatments. According to the reviewing committee, the project of Prof. El Aidy ‘addresses the growing question of the role of the microbiota in the Parkinson’s Disease and of drug-bugs interactions’.
Last modified: | 23 May 2025 08.43 a.m. |
More news
-
29 August 2025
Top Dutch Solar Racing stranded just before the finish line, but returns proudly
From August 24 to 31 this year, the student team Top Dutch Solar Racing will participate in the Bridgestone World Solar Challenge. This page will keep you up to date on the latest developments during and around the race.
-
21 August 2025
Upconversion nanoparticles to aid the application of molecular motors
Scientists from Groningen University and the University of Amsterdam have developed upconversion nanoparticles to assist in powering molecular motors.
-
19 August 2025
Bruno Ehrler appointed new director of AMOLF
Honorary professor Bruno Ehrler of the University of Groningen has been appointed as the new director of AMOLF, the NWO Institute for research into functional complex matter.